D. Braumann
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 10%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
Papers in
- Co-authors
- Axel Stang (6 shared papers)Carsten Bokemeyer (3 shared papers)W. Teichmann (5 shared papers)Roman Fischbach (1 shared paper)Karl‐Friedrich Becker (4 shared papers)Philippe Vergauwe (3 shared papers)Eric Van Cutsem (3 shared papers)Jacques De Grève (3 shared papers)
In The Last Decade
D. Braumann
28 papers receiving 560 citations
Peers
Comparison fields: 5 of 49
- Hepatology 129
- Oncology 260
- Hematology 91
- Pulmonary and Respiratory Medicine 113
- Pathology and Forensic Medicine 48
Countries citing papers authored by D. Braumann
This map shows the geographic impact of D. Braumann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Braumann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Braumann more than expected).
Fields of papers citing papers by D. Braumann
This network shows the impact of papers produced by D. Braumann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Braumann. The network helps show where D. Braumann may publish in the future.
Co-authors
The 25 scholars most cited alongside D. Braumann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 128 | |
| 2 | 2009 | 103 | |
| 3 | 2009 | 50 | |
| 4 | 2005 | 45 | |
| 5 | High dose chemotherapy with busulfan, cyclophosphamide, and etoposide as conditioning regimen for allogeneic bone marrow transplantation for patients with acute myeloid leukemia in first complete remission. | 1997 | 28 |
| 6 | 2006 | 25 | |
| 7 | 1998 | 24 | |
| 8 | 1993 | 22 | |
| 9 | 1998 | 21 | |
| 10 | 2000 | 21 | |
| 11 | 1992 | 18 | |
| 12 | 2002 | 15 | |
| 13 | 2005 | 14 | |
| 14 | Treatment of metastatic colorectal carcinoma with a combination of fluorouracil and recombinant interferon alfa-2b: preliminary data of a phase II study. | 1992 | 13 |
| 15 | 2000 | 9 | |
| 16 | 1987 | 6 | |
| 17 | 2004 | 6 | |
| 18 | 2007 | 5 | |
| 19 | 2004 | 3 | |
| 20 | 2010 | 3 |
About D. Braumann
D. Braumann is a scholar working on Oncology, Surgery, Hematology, Pathology and Forensic Medicine and Emergency Medicine, having authored 28 papers that have together received 571 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (8 papers), Cancer Treatment and Pharmacology (6 papers), Hematopoietic Stem Cell Transplantation (3 papers), Cancer Diagnosis and Treatment (3 papers), Hematological disorders and diagnostics (3 papers), Acute Myeloid Leukemia Research (3 papers), Genetic factors in colorectal cancer (3 papers) and Inflammatory mediators and NSAID effects (2 papers). The work is most often cited by research in Hepatology (129 citations), Oncology (260 citations), Hematology (91 citations), Pulmonary and Respiratory Medicine (113 citations) and Pathology and Forensic Medicine (48 citations). D. Braumann has collaborated with scholars based in Germany, Belgium and Estonia. Frequent co-authors include Axel Stang, Carsten Bokemeyer, W. Teichmann, Roman Fischbach, Karl‐Friedrich Becker, Philippe Vergauwe, Eric Van Cutsem, Jacques De Grève, Muriel Debois and Ullrich Bethe. Their work appears in journals such as Journal of Clinical Oncology, Annals of Hematology, European Journal of Cancer, Bone Marrow Transplantation and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.